HX Diagnostics takes $4.7M for disease diagnostics
HX Diagnostics, maker of quick-acting diagnostic tests for infectious diseases, brought in $4.7 million in equity and securities, according to a filing with the SEC. The company has previously been backed by Kleiner Perkins Caufield & Byers.
Next Story: Financial reporting software maker HyperRoll sells off assets to Oracle
Previous Story: Lunch.com’s Twitter Lists make every day #followfriday
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.